EU approves upscaling of Moderna vaccine in US production facilities

The EMA CHMP has given the stamp of approval for US medical company Moderna to increase its production of the active substance in the firm's coronavirus vaccine in two of the company's US facilities.
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has given the green light for the US pharmaceutical company Moderna to increase the production of the active substance in the firm's covid-19 vaccine known as Spikevax in two of the firm's factories on US soil.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading